echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Outstanding progress has been made in Lianhua Qingwen series research on the prevention and treatment of new coronary pneumonia

    Outstanding progress has been made in Lianhua Qingwen series research on the prevention and treatment of new coronary pneumonia

    • Last Update: 2022-04-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On March 19, a media briefing session on Lianhua Qingwen Capsules for the prevention and treatment of new coronavirus pneumonia was held, at which the latest research progress of Lianhua Qingwen capsules/granules in the prevention and treatment of new coronary pneumonia was released


    Gathering famous prescriptions from the three dynasties to play an active role in the prevention and control of the world epidemic

    At the meeting, Professor Jia Zhenhua from the State Key Laboratory of Collateral Disease Research and Innovative Traditional Chinese Medicine gave a report entitled "Give full play to the advantages of traditional Chinese medicine and play a greater role in the prevention and control of the Omicron epidemic"


    Professor Jia Zhenhua from the State Key Laboratory of Collateral Disease Research and Innovative Traditional Chinese Medicine gave a report titled "Give full use of the advantages of traditional Chinese medicine to play a greater role in the prevention and control of the Omicron epidemic"


    Lianhua Qingwen has obtained definite clinical research evidence for the prevention and treatment of new coronary pneumonia


    Since the outbreak of COVID-19, Lianhua Qingwen capsules/granules have been widely used and played an important role in domestic epidemic prevention and control


    New crown pneumonia is preventable and curable, and reliable evidence is obtained

    Professor Hou Yunlong from the State Key Laboratory of Collateral Disease Research and Innovative Traditional Chinese Medicine gave a report titled "Basic Research on the Prevention and Treatment of Viral Respiratory Diseases with Chinese Medicine Lianhua Qingwen"


    Professor Hou Yunlong of the State Key Laboratory of Collateral Disease Research and Innovative Traditional Chinese Medicine pointed out in a report titled "Basic Research on the Prevention and Treatment of Viral Respiratory Diseases with Traditional Chinese Medicine Lianhua Qingwen", starting from the outbreak in Wuhan, the focus on Lianhua Qingwen's anti-new coronavirus A series of basic and clinical research has been carried out


    Professor Yuan Yadong from the Second Hospital of Hebei Medical University made a report entitled "Study on the preventive effect of Lianhua Qingwen Capsule on close contacts of new coronavirus pneumonia"


    Professor Yuan Yadong from the Second Hospital of Hebei Medical University introduced the real-world research situation of "Lianhua Qingwen Capsules for the Prevention of Novel Coronavirus Pneumonia" in a report titled "Research on the Prevention Effect of Lianhua Qingwen Capsules on New Coronary Virus Pneumonia Close Contacts"


    At present, under the new situation that the mutant strain of Omicron is impacting our country, it is of great practical significance to make good use of Chinese patent medicine to carry out mass prevention and treatment


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.